Dr Greg Baxter
Dr. Baxter is founder of Hurel Corporation, a biotechnology company developing cell-based microfluidic biochips for drug discovery and development applications. He is the key inventor of the animal-on-a-chip technology and is an Adjunct Associate Professor with the Department of Biomedical Engineering at Cornell University. Prior to Hurel, Dr. Baxter was a Senior Scientist at the Cornell Nanoscale Science and Technology Facility and the Biotechnology Liaison for the National Nanofabrication Users Network. Prior to Cornell, he held various research positions at Molecular Devices Corporation. He received his Ph.D. from the University of California and did his postdoctoral research at Syntex Research.